Market: NASD |
Currency: USD
Address: 7599 Anagram Drive
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
📈 NeuroOne Medical Technologies Corporation Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$1.45
-
Upside/Downside from Analyst Target:
89.74%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
100-200%
-
Upcoming Earnings Date:
2025-12-16
-
EPS Estimate:
-0.06
💰 Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2021 |
- |
$0.333333 |
- |
2021-04-01 |
- |
Stock split |
Total Amount for 2021: $0.333333 |
📅 Earnings & EPS History for NeuroOne Medical Technologies Corporation
Date | Reported EPS |
---|
2025-12-16 (estimated upcoming) | - |
2025-08-14 | -0.03 |
2025-05-13 | -0.07 |
2025-02-12 | 0.06 |
2024-02-13 | -0.14 |
2023-12-14 | -0.13 |
2023-08-14 | -0.2 |
2023-05-12 | -0.21 |
2023-02-13 | -0.11 |
2022-12-22 | -0.09 |
2022-08-11 | -0.17 |
2022-05-12 | -0.19 |
2022-02-14 | -0.18 |
2021-12-15 | -0.22 |
📰 Related News & Research
No related articles found for "neuroone medical".